The apigenin enhancement of CD26 in CRC cells is independent of detectable cytotoxicity, but is accompanied by subsequent decreases in cell growth and profileration as measured by assays of DNA synthesis, energy metabolism and cell population number (Lefort and Blay 2011). This evidence concerns the gene DPP4 and colorectal carcinoma.